Immune reconstitution following peripheral blood stem cell autografting

A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.

Leukemia·2017

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

Bone marrow transplantation·2015

Relapsed multiple myeloma: who benefits from salvage autografts?

Internal medicine journal·2012

When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?

Internal medicine journal·2012

Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency.

Molecular psychiatry·2011

How we mobilize haemopoietic stem cells.

Internal medicine journal·2011

Defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from EBMT Global Committee.

Bone marrow transplantation·2026

Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society for blood and marrow transplantation (EBMT).

Bone marrow transplantation·2026

Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties.

Bone marrow transplantation·2026

Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes.

Bone marrow transplantation·2026

EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT.

Bone marrow transplantation·2026

Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in sickle cell disease: a narrative review of safety, engraftment, and graft-versus-host-disease outcomes in adults and high-risk populations.

Bone marrow transplantation·2026

Association of intraoperative cell salvage combined with standard allogeneic transfusion with hematological parameters and clinical outcomes in pediatric tracheoplasty: a non-randomized cohort study.

Frontiers in pediatrics·2026

Correction: Graft rejection across solid organ transplants: mechanisms, monitoring, and immunosuppressive therapeutics.

Frontiers in surgery·2026

Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients With Posttransplant Lymphoproliferative Disorder: A Single-Center Retrospective Study.

Annals of transplantation·2026

Intercostal nerve block with liposomal bupivacaine versus no regional analgesia after uniportal thoracoscopic surgery: A randomized controlled trial.

JTCVS open·2026

Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study.

Journal of psychosomatic research·2026

Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.

Frontiers in immunology·2026

Related Experiment Videos

Immune reconstitution following peripheral blood stem cell autografting

Related Concept Videos

A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

Relapsed multiple myeloma: who benefits from salvage autografts?

When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?

Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency.

How we mobilize haemopoietic stem cells.

Defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from EBMT Global Committee.

Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society for blood and marrow transplantation (EBMT).

Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties.

Autologous stem cell transplantation in POEMS syndrome: Multicenter real-world treatment patterns and outcomes.

EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT.

Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in sickle cell disease: a narrative review of safety, engraftment, and graft-versus-host-disease outcomes in adults and high-risk populations.

Association of intraoperative cell salvage combined with standard allogeneic transfusion with hematological parameters and clinical outcomes in pediatric tracheoplasty: a non-randomized cohort study.

Correction: Graft rejection across solid organ transplants: mechanisms, monitoring, and immunosuppressive therapeutics.

Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients With Posttransplant Lymphoproliferative Disorder: A Single-Center Retrospective Study.

Intercostal nerve block with liposomal bupivacaine versus no regional analgesia after uniportal thoracoscopic surgery: A randomized controlled trial.

Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study.

Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.

Related Experiment Videos

Immune reconstitution following peripheral blood stem cell autografting

Related Concept Videos

Related Articles